Answers are grounded in this paper and cite their sources.
A live, attenuated form of Mycobacterium bovis, bacillus Calmette-Guérin (BCG), is commonly used as intravesical immunotherapy for non-invasive urothelial bladder carcinoma. While complications are rare, dissemination can occur. A case of mycotic aortic aneurysm following BCG administration with recovery of Mycobacterium bovis in culture is reported. A review of the published experience with this problem is also presented.
No takes yet. Share an insight, caveat, or question.
Holmes et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: